Lupin Limited (BOM:500257)
India flag India · Delayed Price · Currency is INR
1,946.30
+94.70 (5.11%)
At close: Aug 7, 2025

Lupin Company Description

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally.

The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs).

The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies.

In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies.

Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business.

It operates through network consists of labs and collection centers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001.

Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited
CountryIndia
Founded1968
IndustryPharmaceutical Preparations
Employees24,006
CEOVinita Gupta

Contact Details

Address:
Kalpataru Inspire
Mumbai, Maharashtra 400055
India
Phone91 22 6640 2323
Websitelupin.com

Stock Details

Ticker Symbol500257
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Vinita GuptaChief Executive Officer
Ramesh SwaminathanChief Financial Officer
Ravi AgrawalHead of Investor Relations